Nectar Lifesciences Limited

Nectar Lifesciences Ltd. operates as a pharmaceutical company, involved in the manufacturing and sale of medicinal products across India and globally. Its product portfolio includes a range of active pharmaceutical ingredients (APIs) and intermediate compounds. These notably feature various cephalosporins such as cefixime, cefuroxime axetil (both amorphous and crystalline forms), cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefpodoxime proxetil (including sterile variants), cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime + Arginine. The company further provides contract manufacturing services for completed dosage forms. These encompass a variety of pharmaceutical presentations like tablets, capsules, dry powder oral suspensions, granules, and injectables, specifically tailored for cephalosporin drugs. Beyond pharmaceuticals, Nectar Lifesciences also supplies menthol, its derivatives, and empty hard gelatin capsules. Established in 1995, Nectar Lifesciences Limited maintains its primary operations from its headquarters in Chandigarh, India.